BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22526904)

  • 1. Simultaneous medullary and differentiated thyroid cancer: a population-level analysis of an increasingly common entity.
    Wong RL; Kazaure HS; Roman SA; Sosa JA
    Ann Surg Oncol; 2012 Aug; 19(8):2635-42. PubMed ID: 22526904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary thyroid microcarcinoma: a population-level analysis of 310 patients.
    Kazaure HS; Roman SA; Sosa JA
    Cancer; 2012 Feb; 118(3):620-7. PubMed ID: 21717441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases.
    Roman S; Lin R; Sosa JA
    Cancer; 2006 Nov; 107(9):2134-42. PubMed ID: 17019736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prognosis of medullary thyroid carcinoma.
    Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic variables and calcitonin in medullary thyroid cancer.
    Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
    Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis.
    Xu L; Wang WB; Zhao YP; Zhang TP; Liao Q; Chen G; Zhou L; Shu H
    J Surg Oncol; 2012 Aug; 106(2):169-73. PubMed ID: 22354558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
    Kazaure HS; Roman SA; Sosa JA
    Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
    Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
    Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term prognosis of medullary thyroid carcinoma in 39 patients.
    Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
    Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients.
    Goffredo P; Cheung K; Roman SA; Sosa JA
    Ann Surg Oncol; 2013 Mar; 20(3):767-72. PubMed ID: 23111705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous medullary carcinoma and differentiated thyroid cancer. Case report.
    Costanzo M; Marziani A; Papa V; Arcerito MC; Cannizzaro MA
    Ann Ital Chir; 2010; 81(5):357-60. PubMed ID: 21294389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of disease and practice patterns for medullary thyroid cancer.
    Kebebew E; Greenspan FS; Clark OH; Woeber KA; Grunwell J
    J Am Coll Surg; 2005 Jun; 200(6):890-6. PubMed ID: 15922202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous medullary and papillary thyroid cancer: a novel entity?
    Machens A; Dralle H
    Ann Surg Oncol; 2012 Jan; 19(1):37-44. PubMed ID: 21626080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?
    Panigrahi B; Roman SA; Sosa JA
    Ann Surg Oncol; 2010 Jun; 17(6):1490-8. PubMed ID: 20224861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Have 2006 ATA practice guidelines affected the treatment of differentiated thyroid cancer in the United States?
    Goffredo P; Roman SA; Sosa JA
    Thyroid; 2014 Mar; 24(3):463-71. PubMed ID: 23978295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same thyroid should be considered as coincidental.
    Kim WG; Gong G; Kim EY; Kim TY; Hong SJ; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):256-63. PubMed ID: 20447064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
    Leggett MD; Chen SL; Schneider PD; Martinez SR
    Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reevaluating the prognostic significance of age in differentiated thyroid cancer.
    Oyer SL; Smith VA; Lentsch EJ
    Otolaryngol Head Neck Surg; 2012 Aug; 147(2):221-6. PubMed ID: 22467286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
    Bhattacharyya N
    Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.